Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
Effexor
Generic name / active ingredient
venlafaxine
Dosage-form class
Dosage form and presentation as documented in the linked primary label
Route
Oral
Record reviewed
2026-08-23

Copy from the pack in hand

Source-linked reading points

  • Check EFFEXOR XR, venlafaxine, extended-release capsule, labelled strength per capsule and target market first. “XR/extended release” is part of dosage-form identity; it does not make an immediate-release tablet, ordinary capsule or same-class medicine directly convertible by milligrams.
  • The U.S. public EFFEXOR XR label lists 37.5, 75 and 150 mg extended-release capsules and states that capsules are swallowed whole, not divided, crushed, chewed or dissolved. It also lists a specific opening/sprinkling method for this exact capsule when whole swallowing is not possible; that is a product-label exception, not permission to open, split or ‘halve’ every extended-release capsule.
  • The label has relevant warnings about MAOIs, other serotonin/norepinephrine-affecting medicines and multiple medicines. Take pain, cough/cold, migraine, sleep, herbal, alcohol and every prescription product together to a pharmacist or prescribing team for review.
  • Do not suddenly self-stop, irregularly alternate or use someone else’s medicine because of short-term feelings, drowsiness or concern about symptoms. Any taper, stop or conversion needs a prescribing-team plan; acute mental-health risk needs local urgent support.

Reviewed presentation examples — compare every field

  • Venlafaxine 37.5 mg per capsule; 30-capsule bottleNDC 0008-0837-21
  • Venlafaxine 75 mg per capsule; 30-capsule bottleNDC 0008-0833-21
  • Venlafaxine 150 mg per capsule; 30-capsule bottleNDC 0008-0836-21

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-23
Source record
3 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image